JP2016512259A5 - - Google Patents

Download PDF

Info

Publication number
JP2016512259A5
JP2016512259A5 JP2016500760A JP2016500760A JP2016512259A5 JP 2016512259 A5 JP2016512259 A5 JP 2016512259A5 JP 2016500760 A JP2016500760 A JP 2016500760A JP 2016500760 A JP2016500760 A JP 2016500760A JP 2016512259 A5 JP2016512259 A5 JP 2016512259A5
Authority
JP
Japan
Prior art keywords
methyl
chlorophenyl
difluoromethoxy
methoxypyridin
triazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016500760A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016512259A (ja
JP6282721B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/021426 external-priority patent/WO2014158998A1/en
Publication of JP2016512259A publication Critical patent/JP2016512259A/ja
Publication of JP2016512259A5 publication Critical patent/JP2016512259A5/ja
Application granted granted Critical
Publication of JP6282721B2 publication Critical patent/JP6282721B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016500760A 2013-03-14 2014-03-06 Pde4阻害剤としての置換ピリジン及びピラジン化合物 Active JP6282721B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361786288P 2013-03-14 2013-03-14
US61/786,288 2013-03-14
PCT/US2014/021426 WO2014158998A1 (en) 2013-03-14 2014-03-06 Substituted pyridine and pyrazine compounds as pde4 inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018009464A Division JP6505878B2 (ja) 2013-03-14 2018-01-24 Pde4阻害剤としての置換ピリジン及びピラジン化合物

Publications (3)

Publication Number Publication Date
JP2016512259A JP2016512259A (ja) 2016-04-25
JP2016512259A5 true JP2016512259A5 (enExample) 2017-04-06
JP6282721B2 JP6282721B2 (ja) 2018-02-21

Family

ID=51530139

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016500760A Active JP6282721B2 (ja) 2013-03-14 2014-03-06 Pde4阻害剤としての置換ピリジン及びピラジン化合物
JP2018009464A Active JP6505878B2 (ja) 2013-03-14 2018-01-24 Pde4阻害剤としての置換ピリジン及びピラジン化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018009464A Active JP6505878B2 (ja) 2013-03-14 2018-01-24 Pde4阻害剤としての置換ピリジン及びピラジン化合物

Country Status (17)

Country Link
US (8) US20160009691A1 (enExample)
EP (2) EP2970212B1 (enExample)
JP (2) JP6282721B2 (enExample)
KR (1) KR102232221B1 (enExample)
CN (2) CN105143207B (enExample)
AU (2) AU2014241430B2 (enExample)
BR (1) BR112015022474B1 (enExample)
CA (1) CA2895209C (enExample)
DK (1) DK3345902T3 (enExample)
ES (1) ES2769181T3 (enExample)
IL (1) IL240804B (enExample)
MX (1) MX370188B (enExample)
NZ (1) NZ711587A (enExample)
RU (1) RU2668073C2 (enExample)
SG (2) SG11201504709PA (enExample)
TW (2) TWI623523B (enExample)
WO (1) WO2014158998A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014241430B2 (en) * 2013-03-14 2018-04-26 Dart Neuroscience (Cayman) Ltd. Substituted pyridine and pyrazine compounds as PDE4 inhibitors
EP3519816A4 (en) * 2016-09-29 2020-05-06 The Regents of the University of California CONNECTIONS FOR INCREASING NEURONAL PLASTICITY
CA3135420A1 (en) * 2018-04-05 2019-10-10 Universiteit Hasselt Selective pde4d inhibitors against demyelinating diseases
CN109438434B (zh) * 2018-11-19 2021-05-04 华南农业大学 一种含噁唑环的2-氰基亚氨基噻唑烷类化合物及其制备方法和应用
WO2020176597A1 (en) 2019-02-27 2020-09-03 The Regents Of The University Of California N-substituted indoles and other heterocycles for treating brain disorders
KR102946120B1 (ko) 2019-02-27 2026-03-30 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 뇌 장애를 치료하기 위한 아제피노-인돌 및 다른 헤테로사이클
JP2022531129A (ja) * 2019-04-23 2022-07-06 テトラ ディスカバリー パートナーズ インコーポレイテッド Pde4d阻害剤としての3-ヒドロキシ-2-フェニル-6-(ピラゾール-4-イルメチル)ピリジン誘導体
WO2020227312A1 (en) * 2019-05-06 2020-11-12 Calcimedica, Inc. Synthesis of crac channel inhibitors
HRP20220797T1 (hr) * 2019-11-07 2022-10-14 Small Pharma Ltd Spojevi
EP4192828A1 (en) 2020-08-04 2023-06-14 Nura Bio, Inc. Substituted pyridine derivatives as sarm1 inhibitors
CN111995585B (zh) * 2020-08-04 2022-01-25 常州大学 嘧啶乙酰胺类化合物及其作为磷酸二酯酶pde2活性抑制剂的应用
WO2022060812A1 (en) 2020-09-16 2022-03-24 Nura Bio, Inc. Substituted pyridine derivatives as sarm1 inhibitors
JP7791898B2 (ja) 2020-11-13 2025-12-24 カルシメディカ,インク. Cracチャネル阻害剤の合成の改善
WO2022221415A2 (en) 2021-04-13 2022-10-20 The Regents Of The University Of California Tetracyclic compounds for treating brain disorders
KR20240041987A (ko) 2021-07-28 2024-04-01 누라 바이오, 인크. Sarm1 억제제로서 치환된 피리딘 유도체
JP2025502615A (ja) 2021-12-15 2025-01-28 デリックス セラピューティクス,インク. フェノキシおよびベンジルオキシ置換サイコプラストゲンならびにその使用
CN116265440B (zh) * 2021-12-16 2024-09-27 贵州大学 一种水杨酮拼接吡啶酮类化合物及其制备方法及应用
EP4562001A4 (en) * 2022-07-27 2026-08-19 Nura Bio Inc Substituted pyridine derivatives as sarm1 inhibitors
EP4596554A4 (en) 2022-09-29 2025-12-10 Suzhou Arkbiopharmaceutical Co Ltd Fused AZA Cyclic Compound, its Preparation Process and its Use in Medicine
CN116082254B (zh) * 2022-12-28 2025-04-11 浙江永太科技股份有限公司 一种1-烷基-1,2,4-三氮唑-3-甲醇的制备方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
AU1504599A (en) 1997-12-17 1999-07-05 Shionogi & Co., Ltd. Novel pyridine compounds
US7868015B2 (en) 2000-08-10 2011-01-11 Cold Spring Harbor Laboratory Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
US7947731B2 (en) 2000-08-10 2011-05-24 Cold Spring Harbor Laboratory Augmented cognitive training
US9931318B2 (en) 2003-04-08 2018-04-03 Dart Neuroscience (Cayman) Ltd. Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
GB0111078D0 (en) 2001-05-04 2001-06-27 Novartis Ag Organic compounds
AR037517A1 (es) 2001-11-05 2004-11-17 Novartis Ag Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
TW200304375A (en) 2001-12-06 2003-10-01 Maxia Pharmaceuticals Inc 2-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer
RU2356893C2 (ru) 2002-11-19 2009-05-27 Мемори Фармасьютиклз Корпорейшн Ингибиторы фосфодиэстеразы 4
GB0229281D0 (en) 2002-12-16 2003-01-22 Novartis Ag Organic compounds
US20050020587A1 (en) 2003-07-25 2005-01-27 Pfizer Inc Nicotinamide derivatives useful as PDE4 inhibitors
MY141255A (en) * 2003-12-11 2010-03-31 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
KR101267392B1 (ko) * 2004-06-30 2013-05-23 주식회사 씨앤드씨신약연구소 피리딘 유도체 및 그의 제조방법
GB0425572D0 (en) 2004-11-19 2004-12-22 Glaxo Group Ltd 1,7-Naphthyridines
WO2006124874A2 (en) * 2005-05-12 2006-11-23 Kalypsys, Inc. Inhibitors of b-raf kinase
US7829713B2 (en) 2006-02-28 2010-11-09 Helicon Therapeutics, Inc. Therapeutic piperazines
EP2465850B1 (en) 2006-02-28 2016-11-23 Dart Neuroscience (Cayman) Ltd Therapeutic compounds
HRP20090395T1 (hr) 2006-04-19 2009-08-31 Boehringer Ingelheim International Gmbh Dihidrotienpirimidini za liječenje upalnih bolesti
WO2007123953A2 (en) * 2006-04-19 2007-11-01 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
WO2007135026A2 (de) 2006-05-24 2007-11-29 Boehringer Ingelheim International Gmbh Substituierte pteridine als therapeutika
EP2074096B1 (en) * 2006-10-04 2012-06-27 F. Hoffmann-La Roche AG 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as hdl-cholesterol raising agents
AU2008254907A1 (en) 2007-05-15 2008-11-27 Helicon Therapeutics, Inc. Methods of identifying genes involved in memory formation using small interfering RNA(siRNA)
US8222243B2 (en) 2007-08-27 2012-07-17 Dart Neuroscience (Cayman) Ltd Therapeutic isoxazole compounds
JP5529746B2 (ja) 2007-11-21 2014-06-25 デコード ジェネティクス イーエイチエフ 炎症性疾患、心臓血管疾患及び中枢神経系障害を治療するための置換されたベンゾアゾールpde4阻害剤
WO2009067597A1 (en) 2007-11-21 2009-05-28 Decode Genetics Ehf 4- (or 5-) substituted catechol derivatives
CN103351390A (zh) * 2007-11-21 2013-10-16 解码遗传Ehf公司 用于治疗肺部和心血管病症的联芳基pde4 抑制剂
EP2222638A2 (en) * 2007-11-21 2010-09-01 Decode Genetics EHF Biaryl pde4 inhibitors for treating inflammation
WO2010003084A2 (en) 2008-07-02 2010-01-07 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
WO2010056195A1 (en) 2008-11-14 2010-05-20 Astrazeneca Ab New compounds 575
WO2010059836A1 (en) 2008-11-20 2010-05-27 Decode Genetics Ehf Substituted aza-bridged bicyclics for cardiovascular and cns disease
JP2013540145A (ja) * 2010-10-21 2013-10-31 ウニベルシテート デス ザールランデス コルチゾール依存性疾患の治療用の選択的cyp11b1阻害剤
AU2014241430B2 (en) * 2013-03-14 2018-04-26 Dart Neuroscience (Cayman) Ltd. Substituted pyridine and pyrazine compounds as PDE4 inhibitors

Similar Documents

Publication Publication Date Title
RU2015137615A (ru) Замещенные пиридиновые и пиразиновые соединения в качестве ингибиторов pde4
JP2014528446A5 (enExample)
RU2019118623A (ru) Пирролопиримидины в качестве потенциаторов мвтр
JP2007523182A5 (enExample)
RU2372347C2 (ru) Соединения тетразола и их применение в качестве антагонистов метаботропного рецептора глутамата
JP2017500364A5 (enExample)
DK2491038T3 (da) Disubstituerede octahydropyrrolo [3,4-c]pyrroler som orexin receptormodulatorer
JP2019504854A5 (enExample)
JP2018524331A5 (enExample)
RU2012146246A (ru) Антибактериальные производные изохинолин-3-илмочевины
JP2013508403A5 (enExample)
JP2013518046A5 (enExample)
JP2018535999A5 (enExample)
JP2016519096A5 (enExample)
JP2016514718A5 (enExample)
JP2014531465A5 (enExample)
JP2015514072A5 (enExample)
JP2017502049A5 (enExample)
JP2014518214A5 (enExample)
RU2012133475A (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
JP2015528022A5 (enExample)
IL187690A (en) Derivatives 1, 2, 4 - Triazolo - 1, 6 - Naphthiridines as inhibitors of AKT activity for use in the preparation of drugs for the treatment of cancer
SI2763982T1 (en) Substituted benzylindazoles for use as inhibitors of Bub kinase in the treatment of hyperproliferative diseases
JP2014521711A5 (enExample)
JP2014518220A5 (enExample)